The RIVR Disclosure.

We have spent five volumes of this series asking the same question and mostly not getting an answer. BRĒZ told us its Lion's Mane dose in wet mushroom weight, which made 33 milligrams of extract read as 2,200. FK+ said "no fairy dusting ever" and then put all thirteen of its botanicals inside a proprietary blend with no numbers at all. Ayrloom sidestepped the problem entirely by not using functional botanicals. Cann and Wynk don't either.

RIVR answers the question. On every product page, for every SKU, the brand publishes a milligram figure for each mushroom and adaptogen in the can, alongside the cannabinoid dose and the caffeine content. Five functional ingredients across the line, five numbers. No proprietary blend. No wet weight. This is the first brand in this series where the Botanical Module could run the way it was designed to run, and that alone makes RIVR worth a volume.

What the numbers show is more interesting than a clean win or a clean miss. Two of the four botanicals clear the clinical thresholds in the literature. Two don't. The caffeine — the ingredient nobody markets as functional — is the most reliably active thing in the formula. And the brand's lab-results page, which is genuinely better than most, contains one document-level problem that a careful reader should know about.

RIVR is also, separately from all of this, owned outright by a federally recognized tribe, which is a real and structurally verifiable fact about the company and not a marketing gesture. It deserves its own section, handled precisely.

Who owns this, precisely.

RIVR is owned and operated by the Soboba Economic Development Corporation, which is wholly owned by the Soboba Band of Luiseño Indians, a federally recognized tribe based in San Jacinto, Riverside County, California. The brand's own legal page states the entity as "Soboba Economic Development Corporation DBA RIVR." SEDC Director Sasha Pachito told BevNET the venture is "100% owned" and funded by the tribe through the corporation.

The framing the tribe uses for the venture is worth quoting rather than paraphrasing, because it is specific. Pachito: "RIVR is unique in the sense that it is a tribal export. It is our first product that generates revenue beyond our reservation base showing a tribal capability to create, market and sell a product." And on the economics: "The goal of the SEDC is to provide for the next seven generations. This means we not only think of current economic gains but also of our future generations." North's version of the same idea: unlike gaming or tourism, which generate revenue by bringing visitors onto tribal land, RIVR is "a Native American-owned product that's going out to the world."

On "1,000 years of ancestral wisdom."

The brand's central tagline is that its teas are "born from ancestral wisdom," and a reader is entitled to know what that claim does and does not assert. Read closely, RIVR's own copy is more careful than the tagline suggests, and the careful reading is the one worth reporting.

The botanicals in the formula are not Luiseño. Yerba mate is South American. RIVR's own ingredient pages credit reishi to Traditional Chinese Medicine "for over 2,000 years" and ashwagandha to Ayurvedic medicine "over 3,000 years." Hibiscus is attributed to ancient Egypt. The one Native-adjacent attribution is soft and hedged in the brand's own words — lavender, "cherished by certain Native American tribes." The general claim RIVR makes is that it "utilizes nature's functional ingredients the same way Native Americans and other Indigenous people have pre-modern day medicine," which is a statement about Indigenous plant use broadly, not about Luiseño ethnobotany specifically.

The one genuinely place-specific claim is about flavor rather than function: the profiles "pay homage to the fruits and herbs found growing throughout the Tribe's reservation." Prickly pear, blackberry, lemon, lavender.

Six SKUs, three flavors, two formats.

The architecture is simple and smart: three flavor platforms, each sold in a dosed and an undosed version. The undosed line is a genuine functional beverage that can be sold in the natural channel; the dosed line is the same liquid with 5 mg of hemp-derived Δ9 added. North described the logic to BevNET plainly: "From the start, the goal was to diversify and limit our risk around being pigeonholed into hemp only."

No minor cannabinoids and no CBD are declared on any SKU, and the lab reports confirm none are present — CBD, CBN, CBC, CBDV and THCV all read not-detected, CBG below the limit of quantitation. This is a straight Δ9 product with no entourage architecture, which makes the cannabinoid plotting trivially simple and means the interesting pharmacology is all on the botanical side.

On cannabinoid accuracy, the numbers are good. The November 2025 Anresco reports put Adventure Raspberry Hibiscus at 4.75 mg against a 5 mg label and Serene Blackberry Lavender at 4.76 mg — both within 5% and both erring slightly low, which is the direction you would rather a beverage err.

Running the Botanical Module for real.

Here is what five volumes of asking has been building toward. RIVR discloses the doses, so the Module can actually compute. But there is one judgment call to make first, and it materially changes the answer.

RIVR's lab documentation specifies its mushroom inputs as "8:1 extract." That means 150 mg of Lion's Mane extract is derived from roughly 1,200 mg of starting material. Whether to credit that ratio is the whole question. Taken at face value, RIVR's mushrooms are dosed generously. Taken conservatively — scoring only the extract mass in the can — they look thin. We think the honest thing is to show both readings and say which we favor.

Our read: credit the ratio, with a stated reservation. An 8:1 designation is a disclosed, checkable formulation fact, and refusing to credit it would punish RIVR for volunteering information other brands withhold. But 8:1 is a mass-yield ratio, not a standardization to any marker compound — hericenones for Lion's Mane, cordycepin for cordyceps, triterpenes for reishi. RIVR publishes no marker standardization, so the ratio tells us how much mushroom went in, not how much of the active came out. It also appears only inside a linked PDF, never on a product page where a buyer would see it.

On that reading, the AWAKEN and ADVENTURE mushroom stack is genuinely dosed: Lion's Mane at more than double the cognition-study threshold and cordyceps just over its endurance-literature floor. The SERENE and PEACE stack is not: reishi at 60% of threshold and ashwagandha at a third of the KSM-66 stress floor, with no standardization stated and no extract ratio given for the ashwagandha at all.

The caffeine is the active ingredient.

The most pharmacologically reliable thing in an AWAKEN or ADVENTURE can is not a mushroom. It is 100 milligrams of caffeine — twice the threshold at which alertness effects are measurable in adult populations, and roughly an average cup of coffee. Whatever the mushrooms contribute, the caffeine is doing the work a drinker will actually notice within the hour.

This is not a criticism; it is a description of where the effect comes from, and RIVR is upfront about the caffeine being there. But it does complicate the marketing frame. The brand's four stated benefits lead with "LASTING ENERGY — yerba mate and mushrooms deliver sustainable energy without the crash." The yerba mate half of that is well supported at 100 mg. The mushroom half is a multi-week nootropic proposition, not a same-session energy one, even at the generous reading of the dose.

One smaller inconsistency: RIVR's marketing describes "100 mg natural caffeine from yerba mate," but the ingredient panel published by a retailer lists "Caffeine (From Green Tea)" as a discrete added ingredient alongside the yerba mate extract. Both can be partly true — mate contributes some caffeine — but the 100 mg figure appears not to be purely mate-derived. RIVR does not publish an ingredient panel on its own product pages, which is the gap that makes this ambiguous.

The lab page is above average, with one real problem.

RIVR maintains a lab-results page with six PDFs, one per SKU, each labelled with a batch code. That is more than most hemp beverage brands do and more than either BRĒZ or FK+ manage. The dosed SKUs are tested by Anresco Laboratories of San Francisco, ISO/IEC 17025:2017 accredited, with November 2025 analysis dates — current, not stale. Potency results are tight. Credit where due.

Three things a careful reader should still know.

First, the Anresco reports are cannabinoid-profile only. No pesticides, no heavy metals, no residual solvents, no microbials. For a consumable beverage that is a meaningful gap, and it is not disclosed as a limitation anywhere on the lab page.

Second, and most consequential: the mushroom quantities are not measured. The Vanguard Laboratory report for the functional SKUs lists "Lions Mane 8:1 extract 142.00 mg/12 oz" and "Cordyceps 8:1 extract 150.00 mg/12 oz" with the method column reading "Calculated by Input." That is a formulation record — a statement of what was added — not an analytical measurement of what is in the can. Only the Δ9 line uses an actual instrument method. So the botanical doses this entire review has been crediting are disclosed but not independently verified. That is still far better than undisclosed. It is not the same as verified, and RIVR's lab page does not make the distinction visible.

Third, ashwagandha is absent from the Peace COA entirely. The report lists only reishi. The 100 mg ashwagandha on the label has no corresponding line, not even a calculated one. Separately, the Lion's Mane calculated figure reads 142 mg where the product page says 150, and the functional-SKU reports carry a best-by date of September 2025 that has passed while still being posted as current results.

And the batch codes don't reconcile. The lab page labels the dosed SKUs with codes like "Batch-056E4253A41," while the Anresco PDFs identify their samples as Lot DR008 and DR007. Those are different systems, and we found nothing indicating a can-side code a buyer could match to either. As with every other brand in this series, a customer holding a can cannot verify they are looking at that can's certificate.

The California irony.

RIVR states its regulatory position plainly in its product FAQs: the teas are "federally legal per the 2018 Farm Bill and available for sale in regions where hemp-derived THC is permitted," and the brand "ships legally to 35 states." The published list is 34 states plus the District of Columbia.

California is not on it. The tribe's own home state banned hemp-derived THC products by emergency action days before RIVR's scheduled launch. Pachito, to Beard Bros: "While California's ban on hemp-derived THC products significantly created costly issues during our launch and handicapped us from selling RIVR across one of the largest markets for THC infused beverages, it has not stopped our mission."

It is worth being careful about what this does and does not mean. RIVR's public legal framing is straightforwardly Farm Bill compliance — not tribal sovereignty. Nothing in the company's materials claims that tribal status exempts the product from state hemp rules, and the brand's own terms of use specify California law and California courts rather than tribal jurisdiction. Reporting has noted that the tribe's casino and gas station serve as California points of sale; we report that as sourced and take no position on its legal basis.

The strategic response is the undosed line, and North is candid about it: "It is a tricky landscape that you have to monitor in real time. One state could swing one way or the other very quickly and so you have to be aware not to over-invest necessarily in one area or be completely bought in to then have the rug pulled out from you." AWAKEN and PEACE exist so RIVR has a product that survives any regulatory outcome — and, not incidentally, they are the SKUs where the mushroom dosing has to carry the entire effect claim on its own.

What disclosure actually buys.

Six volumes in, the shape of the category is clear enough to state as a finding. Cannabinoid disclosure across this industry has become genuinely good, because a compliance regime forced it into existence. Botanical disclosure has not, because the dietary-supplement framework permits proprietary blends and makes per-ingredient numbers optional. Most brands take the option.

RIVR didn't, and the interesting thing is what that cost them. Publishing the numbers meant publishing that reishi is at 60% of threshold and ashwagandha at a third of it. A proprietary blend would have concealed both, and no reviewer — including this one — could have said a word about it. The brand chose a form of transparency that generates a mixed review instead of no review at all.

That is a trade we would like more brands to make, and it is worth being explicit that our verdict rewards it. RIVR earns a recommendation with two named reservations. FK+ earns "promising, pending disclosure" for a product whose cannabinoid engineering is arguably better. The difference is not formulation quality; it is that one of them let us check.

The next volume in this series will be the one we have been avoiding: the cannabinoid-purist counterpoint, Cann, which refuses the botanical overlay entirely on principle and has done so consistently since before the category existed. After six brands of watching functional claims outrun functional doses, there is an argument that refusing the whole move was the more rigorous position all along.